Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis

Purpose: In this study, we intended to compare and rank the efficacy and acceptability of antiseizure medications (ASMs) for adjunctive treatment of children with drug-resistant focal-onset seizures.Method: We conducted a computerized search of PubMed, EMBASE, Cochrane Library, Web of Science, and G...

Full description

Bibliographic Details
Main Authors: Lanlan Zhang, Yuehong Li, Weikai Wang, Chengzhong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.978876/full
_version_ 1798006065485316096
author Lanlan Zhang
Yuehong Li
Weikai Wang
Chengzhong Wang
author_facet Lanlan Zhang
Yuehong Li
Weikai Wang
Chengzhong Wang
author_sort Lanlan Zhang
collection DOAJ
description Purpose: In this study, we intended to compare and rank the efficacy and acceptability of antiseizure medications (ASMs) for adjunctive treatment of children with drug-resistant focal-onset seizures.Method: We conducted a computerized search of PubMed, EMBASE, Cochrane Library, Web of Science, and Google Scholar to identify eligible randomized controlled trials (RCTs) published before 31 May 2022. We included studies evaluating the efficacy and tolerability of antiseizure medications for children with drug-resistant focal-onset seizures. The efficacy and safety were reported in terms of responder and dropout rate along with serious adverse events, the outcomes were ranked with the surface under the cumulative ranking curve (SUCRA).Results: A total of 14 studies (16 trials) with 2,464 patients were included, involving 10 active antiseizure medications. For the primary endpoint of at least 50% reduction in focal-onset seizures, the surface under the cumulative ranking curve ranking suggested that lamotrigine and levetiracetam were more effective as compared with other antiseizure medications; moreover, levetiracetam had the highest probability of rank first for achieving seizure freedom. Concerning tolerability, oxcarbazepine and eslicarbazepine acetate were associated with higher dropout rates relative to other antiseizure medications and placebo, and topiramate was associated with higher occurrence of side effects. No significant differences were found between active antiseizure medications concerning dropout for side effects.Conclusion: According to the surface under the cumulative ranking curve ranking, lamotrigine, levetiracetam, and oxcarbazepine were more efficacious than other active antiseizure medications in terms of responder rate. Concerning tolerability, oxcarbazepine was more likely to lead to dropout and topiramate was associated with higher occurrence of side effects.
first_indexed 2024-04-11T12:49:01Z
format Article
id doaj.art-e19722df9f0948c9ba2a3fdfe98c440a
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T12:49:01Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-e19722df9f0948c9ba2a3fdfe98c440a2022-12-22T04:23:16ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-12-011310.3389/fphar.2022.978876978876Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysisLanlan ZhangYuehong LiWeikai WangChengzhong WangPurpose: In this study, we intended to compare and rank the efficacy and acceptability of antiseizure medications (ASMs) for adjunctive treatment of children with drug-resistant focal-onset seizures.Method: We conducted a computerized search of PubMed, EMBASE, Cochrane Library, Web of Science, and Google Scholar to identify eligible randomized controlled trials (RCTs) published before 31 May 2022. We included studies evaluating the efficacy and tolerability of antiseizure medications for children with drug-resistant focal-onset seizures. The efficacy and safety were reported in terms of responder and dropout rate along with serious adverse events, the outcomes were ranked with the surface under the cumulative ranking curve (SUCRA).Results: A total of 14 studies (16 trials) with 2,464 patients were included, involving 10 active antiseizure medications. For the primary endpoint of at least 50% reduction in focal-onset seizures, the surface under the cumulative ranking curve ranking suggested that lamotrigine and levetiracetam were more effective as compared with other antiseizure medications; moreover, levetiracetam had the highest probability of rank first for achieving seizure freedom. Concerning tolerability, oxcarbazepine and eslicarbazepine acetate were associated with higher dropout rates relative to other antiseizure medications and placebo, and topiramate was associated with higher occurrence of side effects. No significant differences were found between active antiseizure medications concerning dropout for side effects.Conclusion: According to the surface under the cumulative ranking curve ranking, lamotrigine, levetiracetam, and oxcarbazepine were more efficacious than other active antiseizure medications in terms of responder rate. Concerning tolerability, oxcarbazepine was more likely to lead to dropout and topiramate was associated with higher occurrence of side effects.https://www.frontiersin.org/articles/10.3389/fphar.2022.978876/fullfocal onset seizurenetwork meta-analysisanti-seizure medicationepilepsychildren
spellingShingle Lanlan Zhang
Yuehong Li
Weikai Wang
Chengzhong Wang
Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
Frontiers in Pharmacology
focal onset seizure
network meta-analysis
anti-seizure medication
epilepsy
children
title Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
title_full Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
title_fullStr Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
title_full_unstemmed Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
title_short Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
title_sort comparative antiseizure medications of adjunctive treatment for children with drug resistant focal onset seizures a systematic review and network meta analysis
topic focal onset seizure
network meta-analysis
anti-seizure medication
epilepsy
children
url https://www.frontiersin.org/articles/10.3389/fphar.2022.978876/full
work_keys_str_mv AT lanlanzhang comparativeantiseizuremedicationsofadjunctivetreatmentforchildrenwithdrugresistantfocalonsetseizuresasystematicreviewandnetworkmetaanalysis
AT yuehongli comparativeantiseizuremedicationsofadjunctivetreatmentforchildrenwithdrugresistantfocalonsetseizuresasystematicreviewandnetworkmetaanalysis
AT weikaiwang comparativeantiseizuremedicationsofadjunctivetreatmentforchildrenwithdrugresistantfocalonsetseizuresasystematicreviewandnetworkmetaanalysis
AT chengzhongwang comparativeantiseizuremedicationsofadjunctivetreatmentforchildrenwithdrugresistantfocalonsetseizuresasystematicreviewandnetworkmetaanalysis